SYAHRANI, R. A., LOUISA, M., & WANANDI, S. I. (2019). SENSITIVITY OF BREAST CANCER STEM CELLS (CD24-/CD44+) TO DOXORUBICIN IS ASSOCIATED WITH OXIDATIVE STRESS STATUS. International Journal of Applied Pharmaceutics, 11(6), 91-96. https://doi.org/10.22159/ijap.2019.v11s6.33555